PyInvesting

Market research

ASTEC.NSE Astec LifeSciences Limited

NSE INR Basic Materials

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
16B
P/E ratio
Not available
Analyst target
670
Dividend yield
Not available
Beta
0.15

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Astec LifeSciences Limited is currently in a long term uptrend where the price is trading 18.3% above its 200 day moving average.

From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 3.5.

Astec LifeSciences Limited's total revenue sank by 7.1% to $1B since the same quarter in the previous year.

Its net income has dropped by 42.0% to $71M since the same quarter in the previous year.

Finally, its free cash flow grew by 1690.6% to $188M since the same quarter in the previous year.

Based on the above factors, Astec LifeSciences Limited gets an overall score of 3/5.